Advertisement

BMC Proceedings

, 4:P3 | Cite as

Mastermind-like 1 (MAML-1) as a new metastatic marker in esophageal squamous cell carcinoma

  • Mohammad M Forghanifard
  • Moein Farshchian
  • Reza Raeisossadati
  • Mohammad N Forghani
  • Meysam Moghbeli
  • Hussein Naseh
  • Mohammad R Abbaszadegan
Open Access
Poster presentation

Keywords

Esophageal Squamous Cell Carcinoma Notch Signaling Notch Signaling Pathway Death Program Tumor Cell Type 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Deregulation of the normal cellular processes that mediate cell proliferation, differentiation and death programs, have been seeing in various tumor cell types [1]. Notch signaling pathway that plays fundamental roles in definition of the cell fate and self-renewal is frequently deregulated in human malignancies, by up or down regulation, where it may act either as an oncogene or as a tumor suppressor depending on the cell context [2, 3]. The MAML proteins are transcriptional co-activators of notch signalling that are not only essential for related responses, but also have some regulatory functions in other signaling pathways, including p53 and Wnt/beta-catenin, and therefore have a central role in signaling cross talk of diverse cellular processes such as cell proliferation, differentiation and survival [4].

In current study, the expression of MAML-1 and EGFR genes were analyzed in 44 esophageal squamous cell carcinoma (ESCC) patients with the quantitative (real-time) RT-PCR. Overexpression of these genes was found in 45.5% and 38.6% of ESCC samples respectively. Relative expression of MAML-1 was significantly associated with the lymph node metastasis of tumor cells (P < 0.05).

Since MAML-1 is an essential transcription coactivator of notch signaling pathway and downstream related genes expression, we extrapolated that, notch signaling may contribute in tumor development and metastasis in ESCC, however further studies are required. We report for the first time that MAML-1 gene is overexpressed as a metastasis-related gene in ESCC samples. This indicates that MAML-1 may be a possible metastatic marker of ESCC and a possible good therapeutic target in order to block tumor cell metastasis.

References

  1. 1.
    Allenspach EJ, Maillard I, Aster JC, Pear WS: Notch signaling in cancer. Cancer Biol Ther. 2002, 1: 466-476. 10.4161/cbt.1.5.162.CrossRefPubMedGoogle Scholar
  2. 2.
    Koch U, Radtke F: Notch and cancer: a double-edged sword. Cell Mol Life Sci. 2007, 64: 2746-2762. 10.1007/s00018-007-7164-1.CrossRefPubMedGoogle Scholar
  3. 3.
    Bolós V, Grego-Bessa J, de la Pompa JL: Notch signaling in development and cancer. Endocr Rev. 2007, 28: 339-363. 10.1210/er.2006-0046.CrossRefPubMedGoogle Scholar
  4. 4.
    McElhinny AS, Li J-L, Wu L: Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways. Oncogene. 2008, 27: 5138-5147. 10.1038/onc.2008.228.CrossRefPubMedGoogle Scholar

Copyright information

© Forghanifard et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.

Authors and Affiliations

  • Mohammad M Forghanifard
    • 1
  • Moein Farshchian
    • 2
  • Reza Raeisossadati
    • 2
  • Mohammad N Forghani
    • 3
  • Meysam Moghbeli
    • 2
  • Hussein Naseh
    • 4
  • Mohammad R Abbaszadegan
    • 2
  1. 1.Department of Biological ScienceIslamic Azad University, Damghan BranchDamghanIran (Islamic Republic of)
  2. 2.Human Genetic Division, Immunology Research Center, Avicenna Research InstituteMashhad University of Medical SciencesMashhadIran (Islamic Republic of)
  3. 3.Department of SurgeryOmid Hospital, MUMSMashhadIran (Islamic Republic of)
  4. 4.Department of PathologyOmid Hospital, MUMSMashhadIran (Islamic Republic of)

Personalised recommendations